Hennion & Walsh Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-35,704
Closed -$2.72M 937
2025
Q1
$2.72M Sell
35,704
-8,230
-19% -$630K 0.12% 209
2024
Q4
$3.03M Sell
43,934
-43,522
-50% -$3.13M 0.14% 188
2024
Q3
$6.38M Sell
87,456
-27,195
-24% -$2.01M 0.3% 64
2024
Q2
$7.68M Sell
114,651
-32,261
-22% -$1.25M 0.39% 40
2024
Q1
$3.99M Buy
146,912
+8,877
+6% +$248K 0.21% 115
2023
Q4
$4.28M Sell
138,035
-32,971
-19% -$855K 0.24% 96
2023
Q3
$4.32M Buy
171,006
+14,379
+9% +$329K 0.28% 82
2023
Q2
$3.31M Buy
156,627
+19,740
+14% +$375K 0.2% 127
2023
Q1
$2.33M Buy
136,887
+7,406
+6% +$144K 0.14% 185
2022
Q4
$2.59M Sell
129,481
-25,583
-16% -$494K 0.16% 167
2022
Q3
$3.34M Buy
155,064
+19,114
+14% +$458K 0.22% 118
2022
Q2
$2.68M Sell
135,950
-55,632
-29% -$1.17M 0.17% 161
2022
Q1
$4.5M Buy
191,582
+9,409
+5% +$219K 0.24% 110
2021
Q4
$4.96M Sell
182,173
-35,909
-16% -$1.03M 0.24% 109
2021
Q3
$6.01M Sell
218,082
-15,061
-6% -$395K 0.32% 76
2021
Q2
$6.63M Buy
233,143
+15,448
+7% +$458K 0.35% 65
2021
Q1
$7.42M Buy
+217,695
New +$8.32M 0.45% 45

Other funds holding INSM

Hennion & Walsh Asset Management's INSM Position: Q2 2025 in Review

Hennion & Walsh Asset Management sold out of Insmed (INSM) in Q2 2025, closing a stake of 35,704 shares — an estimated $2.72M sold.

Hennion & Walsh Asset Management first reported a position in INSM in Q1 2021 and held it in 17 quarters. The position peaked at $7.68M in Q2 2024. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Hennion & Walsh Asset Management reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 35,704 Insmed shares in Q2 2025, an estimated $2.72M.
  • Hennion & Walsh Asset Management first reported a position in Insmed in Q1 2021 and held it in 17 quarters.
  • Hennion & Walsh Asset Management's Insmed position peaked at $7.68M in Q2 2024.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.